Help patients save on insulin costs

We understand how important it is for patients to have access to affordable insulin. That’s why we offer affordability solutions to help your diabetes patients get the treatment they need.

Help patients save on insulin costs

We understand how important it is for patients to have access to affordable insulin. That’s why we offer affordability solutions to help your diabetes patients get the treatment they need.

Insulin affordability programs and offers

Hand holding Rx card

MyInsulinRx™

With this savings program, eligible patients may pay $35 for a monthly supply of any combination of Novo Nordisk insulin products, up to 3 vials or 2 packs of pens (up to 35 mL).a

Savings card icon

Savings offers

If your patients have private or commercial insurance, they may be eligible to get savings on their Novo Nordisk insulin.

Hand holding heart icon

Patient Assistance Program (PAP)

If your patients do not have insurance or are enrolled in a Medicare plan and need extra assistance, they may be able to get their insulin free of charge from Novo Nordisk. Novo Nordisk’s PAP is a no-cost program without any registration fees or monthly fees.

Prescription bag with heart icon

Immediate Supply

If patients are at risk of rationing their insulin and have an immediate need, we may be able to help with a one-time offer for a free, short-term supply of Novo Nordisk insulin (up to 3 vials or 2 packs of pens).b This offer is a short-term solution. We are committed to helping patients find a way to afford their insulin and encourage them to revisit the options above to meet their long-term needs.

Additional low-cost insulin options

Insulin vial icon

Human Insulin

Learn about human insulin options that may be more affordable, especially for those without insurance or with high-deductible health insurance plans. For your appropriate patients without insurance coverage, the cost could be as low as $25/vial through several national pharmacy programs.

Pen injector and vial icon

Unbranded Biologics

Learn more about rapid-acting, premixed, and basal insulin Unbranded Biologics offered by Novo Nordisk Pharma, Inc. (NNPI). NNPI is a Novo Nordisk A/S company. This may be a more affordable option depending on a patient’s benefit design and formulary coverage. Out-of-pocket costs for an Unbranded Biologic may count toward your patients’ deductibles.